HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A two-phase model for chronic disease processes under intermittent inspection.

Abstract
A model is developed for chronic diseases with an indolent phase that is followed by a phase with more active disease resulting in progression and damage. The time scales for the intensity functions for the active phase are more naturally based on the time since the start of the active phase, corresponding to a semi-Markov formulation. This two-phase model enables one to fit a separate regression model for the duration of the indolent phase and intensity-based models for the more active second phase. In cohort studies for which the disease status is only known at a series of clinical assessment times, transition times are interval-censored, which means the time origin for phase II is interval-censored. Weakly parametric models with piecewise constant baseline hazard and rate functions are specified, and an expectation-maximization algorithm is described for model fitting. Simulation studies examining the performance of the proposed model show good performance under maximum likelihood and two-stage estimation. An application to data from the motivating study of disease progression in psoriatic arthritis illustrates the procedure and identifies new human leukocyte antigens associated with the duration of the indolent phase. Copyright © 2017 John Wiley & Sons, Ltd.
AuthorsYing Wu, Richard J Cook
JournalStatistics in medicine (Stat Med) Vol. 36 Issue 13 Pg. 2016-2031 (06 15 2017) ISSN: 1097-0258 [Electronic] England
PMID28238209 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2017 John Wiley & Sons, Ltd.
Chemical References
  • HLA Antigens
Topics
  • Algorithms
  • Arthritis, Psoriatic (immunology, pathology)
  • Chronic Disease (epidemiology)
  • Disease Progression
  • HLA Antigens (immunology)
  • Humans
  • Likelihood Functions
  • Markov Chains
  • Models, Statistical
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: